Bendamustine for treatment of chronic lymphocytic leukemia

Author： Chang Julie Elizabeth   Kahl Brad Steven  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.10, 2012-07, pp. : 1495-1505

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New treatment options for chronic lymphocytic leukemia

By Delgado Julio   Baumann Tycho   Santacruz Rodrigo   Montserrat Emili  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 6, 2014-04 ,pp. : 823-832

Informa Healthcare

Access to resources Recommend Favorite

Novel Monoclonal Antibodies for the Treatment of Chronic Lymphocytic Leukemia

By  

Current Cancer Drug Targets, Vol. 8, Iss. 2, 2008-03 ,pp. : 156-171

Bentham Science Publishers

Access to resources Recommend Favorite

Pentostatin in chronic lymphocytic leukemia

By Sauter Craig   Lamanna Nicole   Weiss Mark A  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 9, 2008-09 ,pp. : 1217-1222

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic evaluation of oblimersen sodium for the treatment of chronic lymphocytic leukemia

By Advani Pooja P   Paulus Aneel   Masood Ayesha   Sher Taimur   Chanan-Khan Asher  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 6, 2011-06 ,pp. : 765-774

Informa Healthcare

Access to resources Recommend Favorite

FCR and bevacizumab treatment in patients with relapsed chronic lymphocytic leukemia

By  

Cancer, Vol. 120, Iss. 22, 2014-11 ,pp. : 3494-3501

Blackwell Publishing

Access to resources Recommend Favorite